Wasatch Advisors Inc Outset Medical, Inc. Transaction History

Wasatch Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$14.67 - $21.7 $15.4 Million - $22.8 Million	-1,049,428 Reduced 91.57%	96,662 $1.54 Million
Q2 2022 Aug 12, 2022	BUY	$13.46 - $48.16 $5.93 Million - $21.2 Million	440,842 Added 62.51%	1,146,090 $17 Million
Q1 2022 May 13, 2022	SELL	$34.22 - $47.24 $7.51 Million - $10.4 Million	-219,345 Reduced 23.72%	705,248 $32 Million
Q4 2021 Feb 15, 2022	BUY	$43.29 - $58.77 $22 Million - $29.9 Million	508,082 Added 121.99%	924,593 $42.6 Million
Q3 2021 Nov 12, 2021	BUY	$36.86 - $54.98 $15.4 Million - $22.9 Million	416,511 New	416,511 $20.6 Million

122

41M

63.4K

32.1K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $181M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.